| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section on Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Dr. Keisuke Tsutsumi, Section on Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, 9000 Rockville Pike, Building 10, Room 2D-45, Bethesda, Maryland 20892.
Abstract
Quantitative autoradiography revealed large numbers of angiotensin-II (AT) receptors in the 18-day-old rat embryo. The selective AT-1 antagonist DuP 753 readily competed for AT receptors in liver, lung parenchyma, and choroid plexus, and these receptors are classified as AT-1 receptors. The selective AT-2 displacers CGP 42112 A and/or PD 123177 competed with high affinity with AT bound to most receptors located in skeletal muscle, skin, diaphragm, bronchi, and stomach, and these receptors are classified as AT-2 receptors. The amount of AT-2 receptors in fetal tissues was more than 10-fold higher than that of AT-1 receptors. In skeletal muscle and skin, DuP 753 competed with AT in the presence of 107 M CGP 42112 A, indicating the presence of small numbers of AT-1 receptors. In liver and lung parenchyma, binding to AT-1 receptors was sensitive to guanine nucleotides. AT binding to AT-2 receptors in fetal skin and skeletal muscle was insensitive to guanine nucleotides. AT stimulated phosphoinositide hydrolysis in liver (ED50) 64 nM) and in skin and skeletal muscle (ED60, 62 nM); this was inhibited by DuP 753 (liver IC50, 38 nM; skin and skeletal muscle IC50, 26 nM), but not by PD 123177 in concentrations up to the micromolar range. AT-1 receptors are probably coupled to G-proteins, and their stimulation increases phos-phoinositide hydrolysis. AT-2 receptors may not be linked to G-proteins, their stimulation is not associated with phosphoinositide hydrolysis, and the nature of their second messenger system(s) is presently unknown.
Received March 8, 1991.
This article has been cited by other articles:
![]() |
H. Beaudry, L. Gendron, M.-O. Guimond, M. D. Payet, and N. Gallo-Payet Involvement of Protein Kinase C{alpha} (PKC{alpha}) in the Early Action of Angiotensin II Type 2 (AT2) Effects on Neurite Outgrowth in NG108-15 Cells: AT2-Receptor Inhibits PKC{alpha} and p21ras Activity Endocrinology, September 1, 2006; 147(9): 4263 - 4272. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Hoe, I. Armando, G. Baiardi, T. Sreenath, A. Kulkarni, A. Martianez, and J. M. Saavedra Molecular cloning, characterization, and distribution of the gerbil angiotensin II AT2 receptor Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1373 - R1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gendron, J.-F. Oligny, M. D. Payet, and N. Gallo-Payet Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells J. Biol. Chem., January 31, 2003; 278(6): 3606 - 3614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stoll, A. W.A. Hahn, U. Jonas, Y. Zhao, B. Schieffer, J. W. Fischer, and T. Unger Identification of a Zinc Finger Homoeodomain Enhancer Protein After AT2 Receptor Stimulation by Differential mRNA Display Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Armando, A. Carranza, Y. Nishimura, K.-L. Hoe, M. Barontini, J. A. Terron, A. Falcon-Neri, T. Ito, A. V. Juorio, and J. M. Saavedra Peripheral Administration of an Angiotensin II AT1 Receptor Antagonist Decreases the Hypothalamic-Pituitary-Adrenal Response to Isolation Stress Endocrinology, September 1, 2001; 142(9): 3880 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takekoshi, K. Ishii, Y. Kawakami, K. Isobe, and T. Nakai Activation of Angiotensin II Subtype 2 Receptor Induces Catecholamine Release in an Extracellular Ca2+-Dependent Manner through a Decrease of Cyclic Guanosine 3',5'-Monophosphate Production in Cultured Porcine Adrenal Medullary Chromaffin Cells Endocrinology, July 1, 2001; 142(7): 3075 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Armando, A. Carranza, Y. Nishimura, M. Barontini, T. Ito, and J. M Saavedra Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S130 - S135. [Abstract] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chamoux Involvement of the Angiotensin II Type 2 Receptor in Apoptosis during Human Fetal Adrenal Gland Development J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4722 - 4730. [Abstract] [Full Text] |
||||
![]() |
F. Cote, T. H. Do, L. Laflamme, J.-M. Gallo, and N. Gallo-Payet Activation of the AT2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum J. Biol. Chem., October 29, 1999; 274(44): 31686 - 31692. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gendron*, L. Laflamme*, N. Rivard, C. Asselin, M. D. Payet, and N. Gallo-Payet Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108-15 Cells Mol. Endocrinol., September 1, 1999; 13(9): 1615 - 1626. [Abstract] [Full Text] |
||||
![]() |
H. Yamada, M. Akishita, M. Ito, K. Tamura, L. Daviet, J. Y. A. Lehtonen, V. J. Dzau, and M. Horiuchi AT2 Receptor and Vascular Smooth Muscle Cell Differentiation in Vascular Development Hypertension, June 1, 1999; 33(6): 1414 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Wang, A. F. Moore, R. Ozono, H. M. Siragy, and R. M. Carey Immunolocalization of Subtype 2 Angiotensin II (AT2) Receptor Protein in Rat Heart Hypertension, July 1, 1998; 32(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yang, D. Li, M I. Phillips, P. Mehta, and J. L Mehta Myocardial angiotensin II receptor expression and ischemia-reperfusion injury Vascular Medicine, May 1, 1998; 3(2): 121 - 130. [Abstract] [PDF] |
||||
![]() |
C. Heymes, J.-S. Silvestre, C. Llorens-Cortes, F. Marotte, B. Chevalier, B. I. Levy, B. Swynghedauw, and J.-L. Samuel Cardiac Senescence Is Associated with Enhanced Expression of Angiotensin II Receptor Subtypes Endocrinology, May 1, 1998; 139(5): 2579 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horiuchi, W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau Angiotensin Type 2 Receptor Dephosphorylates Bcl-2 by Activating Mitogen-activated Protein Kinase Phosphatase-1 and Induces Apoptosis J. Biol. Chem., July 25, 1997; 272(30): 19022 - 19026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horiuchi, T. Yamada, W. Hayashida, and V. J. Dzau Interferon Regulatory Factor-1 Up-regulates Angiotensin II Type 2 Receptor and Induces Apoptosis J. Biol. Chem., May 2, 1997; 272(18): 11952 - 11958. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Laflamme, M. d. Gasparo, J.-M. Gallo, M. D. Payet, and N. Gallo-Payet Angiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 Cells. EFFECT COUNTERACTED BY THE AT1 RECEPTORS J. Biol. Chem., September 13, 1996; 271(37): 22729 - 22735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shanmugam, P. Corvol, and J.-M. Gasc Angiotensin II Type 2 Receptor mRNA Expression in the Developing Cardiopulmonary System of the Rat Hypertension, July 1, 1996; 28(1): 91 - 97. [Abstract] [Full Text] |
||||
![]() |
M. Horiuchi, G. Koike, T. Yamada, M. Mukoyama, M. Nakajima, and V. J. Dzau The Growth-dependent Expression of Angiotensin II Type 2 Receptor Is Regulated by Transcription Factors Interferon Regulatory Factor-1 and -2 J. Biol. Chem., August 25, 1995; 270(34): 20225 - 20230. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buisson, L. Laflamme, S. P. Bottari, M. de Gasparo, N. Gallo-Payet, and M. D. Payet A G Protein Is Involved in the Angiotensin AT(2) Receptor Inhibition of the T-Type Calcium Current in Non-differentiated NG108-15 Cells J. Biol. Chem., January 27, 1995; 270(4): 1670 - 1674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |